🔎 Trials Near Me

ホーム › 卵巣がん › コネチカット州

コネチカット州における卵巣がんの臨床試験

コネチカット州内の拠点で、卵巣がんに関する28件の研究が参加者を募集しています。

コネチカット州内の都市

公式研究テキスト(英語)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Yale Cancer Center, New Haven
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Yale Cancer Center, New Haven
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

  • Yale University - Yale University School of Medicine, New Haven
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07360314

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

  • Site 0158 - Hartford HealthCare, Hartford
被験者募集中第2相
18歳以上 · 女性 · 2026/09/29更新 · NCT05128825

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  • Danbury Hospital, Western Connecticut Health Network /ID# 274783, Danbury
  • Yale University School of Medicine /ID# 275794, New Haven
  • Norwalk Hospital /ID# 274561, Norwalk
被験者募集中第2相
18歳以上 · 女性 · 2026/09/29更新 · NCT06890338

Study of AVZO-021 in Patients With Advanced Solid Tumors

  • Avenzo Therapeutics Recruiting Site, New Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT05867251

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, New Have
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/24更新 · NCT07229313

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • UConn Health, Farmington
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Yale University, Yale Cancer Center, New Haven
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

  • Yale Cancer Center, New Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06303505

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  • Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0001), New Haven
被験者募集中第3相
18歳以上 · 女性 · 2026/09/03更新 · NCT06824467

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

  • Smilow Cancer Hospital-Derby Care Center, Derby
  • Smilow Cancer Hospital Care Center-Fairfield, Fairfield
  • Smilow Cancer Hospital Care Center at Greenwich, Greenwich
  • 他8件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/08/19更新 · NCT07001748

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

  • Normunity Investigational Site, New Haven
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07182149

A Study of PHST001 in Advanced Solid Tumors

  • Yale Cancer Center, New Haven
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/12更新 · NCT06840886

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

  • Danbury Hospital, Danbury
  • Smilow Cancer Hospital Care Center at Greenwich, Greenwich
  • Hartford Hospital, Hartford
  • 他5件
被験者募集中
35歳〜50歳 · 女性 · 2026/08/07更新 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Danbury Hospital, Danbury
  • Smilow Cancer Hospital Care Center-Fairfield, Fairfield
  • Smilow Cancer Hospital Care Center at Greenwich, Greenwich
  • 他8件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  • Yale University School of Medicine, New Haven
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/07/28更新 · NCT06161025

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Norwalk Hospital, Norwalk
被験者募集中第2相
8歳以上 · 全性別 · 2026/07/27更新 · NCT05503797

Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer

  • Yale University, New Haven
被験者募集中
18歳以上 · 女性 · 2026/07/20更新 · NCT05761561

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

  • Yale University, New Haven
被験者募集中第1相
18歳以上 · 女性 · 2026/07/06更新 · NCT07226427

Integrated Cancer Repository for Cancer Research

  • Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • Yale University, Yale Cancer Center, New Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/23更新 · NCT06993844

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

  • Hartford Hospital, Hartford
  • Smilow Cancer Hospital at Yale- New Haven, New Haven
  • Yale University School of Medicine, New Haven
被験者募集中第3相
18歳以上 · 女性 · 2026/04/16更新 · NCT05659381

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

  • Yale University, Yale Cancer Center, New Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/27更新 · NCT06395519

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

  • Yale University, New Haven
被験者募集中第1相
18歳以上 · 全性別 · 2026/01/14更新 · NCT06234423

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

  • Smilow Cancer Hospital at Yale - New Haven, New Haven
被験者募集中第2相
18歳以上 · 女性 · 2025/12/23更新 · NCT06690775

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Hartford
  • Massive Bio SYNERGY-AI site, Norwalk
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。